# Field Trip Health & Wellness

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/field-trip-health-wellness

- Industry: Healthcare Specialists
- Headquarters: Toronto, Canada
- Website: www.fieldtriphealth.com
- Total disclosed funding: $20M
- Latest round: Series B (Aug 24, 2020)
- Investors on record: 7

## About

Based in Ontario, Canada, and founded in 2019, Field Trip Health Inc., formerly known as Newton Energy Corporation, provides therapeutic psychedelics solutions for mental health and wellness. The company was co-founded by Mujeeb Jafferi and Ryan Yermus. In August 2020, the company raised its latest Series B funding from What If Ventures, Seven Hound Ventures, Inc., and BT Growth Capital.

The company's solution includes a treatment program using traditional psychedelic practices that combines psychedelic medicine and the therapeutic process. The company offers its service to a person with mental health conditions, including depression, generalized anxiety disorder, and trauma.

The company generates revenue by selling its therapeutic solution into modular blocks. The fee charged by the company depends on the sessions availed.

The company plans to further advance its research and development on psilocybin-producing mushrooms and expand its operation by opening its Santa Monica, California location.

## Funding rounds

- Series B, Aug 24, 2020, $11M — What If Ventures, BT Growth Capital, Seven Hound Ventures
- Series A, Feb 6, 2020, $8.5M — Bolt, Subversive Capital, Chicago Atlantic BDC Advisers, Singhal Health Foundation

## Investors

- Bolt (https://capitalatlas.ai/funds/bolt) — Series A
- Subversive Capital (https://capitalatlas.ai/funds/subversive-capital) — Series A
- Chicago Atlantic BDC Advisers — Series A
- Singhal Health Foundation — Series A
- What If Ventures (https://capitalatlas.ai/funds/what-if-ventures) — Series B
- BT Growth Capital (https://capitalatlas.ai/funds/bt-growth-capital) — Series B
- Seven Hound Ventures (https://capitalatlas.ai/funds/seven-hound-ventures) — Series B